All In Biotech

Drug Trial Radar · NCT05610891

Novel Targeted Radiotherapy in Pediatric Patients With Inoperable Relapsed or Refractory HGG

A Phase 1b, Open-Label, Study of a Novel Targeted Radiotherapy in Children, Adolescents and Young Adults With Inoperable Relapsed or Refractory High-Grade Glioma

Last checked: Nov 19, 2026Latest source record: Oct 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

50

Planned (sponsor's estimate)

Start

Oct 1, 2023

Primary completion

Jun 30, 2027

Study completion Dec 2027

Sponsor

Lead sponsor
Cellectar Biosciences, Inc.Industry
Sponsor type
Industry
Collaborators
National Cancer Institute (NCI)
First posted
Nov 9, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 10 years, up to 25 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this dose finding study is to evaluate the safety and efficacy of 2 different dose levels of CLR 131 in children, adolescents and young adults with relapsed or refractory high-grade glioma (HGG).

Conditions

  • High-Grade Glioma

Interventions

  • CLR 131Drug

    CLR 131 will be administered IV (intravenously) at a dose based on patients' BSA

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety Evaluation of CLR 131Time frame: Assessed throughout the study to 1-year post-infusion follow-up period
  2. Efficacy Evaluation for Progression Free SurvivalTime frame: Day 84 post-infusion follow-up period through 3 years following completion of treatment.

Locations

8 sites in 2 countries. Site status is shown where the registry gives one.

  • Stanford University

    Palo Alto, California

  • Memorial Sloan Kettering Cancer Center

    New York, New York

  • Cincinnati Children's Hospital Medical Center

    Cincinnati, Ohio

  • Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania

  • UT Southwestern Medical Center

    Dallas, Texas

  • Texas Children's Cancer Center, Baylor College of Medicine

    Houston, Texas

  • University of Wisconsin, Carbone Cancer Center

    Madison, Wisconsin

  • Hospital for Sick Children

    Toronto, Ontario, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.